Wolverine Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1352 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1407 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1597 |
|
|
2024
Q3 | – | Sell |
-10,609
| Closed | -$65.6K | – | 1401 |
|
|
2024
Q2 | $65.6K | Buy |
+10,609
| New | +$65.6K | ﹤0.01% | 1151 |
|
|
2024
Q1 | – | Sell |
-16,364
| Closed | -$98K | – | 1289 |
|
|
2023
Q4 | $98K | Buy |
+16,364
| New | +$98K | ﹤0.01% | 1132 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1254 |
|
|
2023
Q2 | – | Sell |
-15,825
| Closed | -$133K | – | 1164 |
|
|
2023
Q1 | $133K | Buy |
+15,825
| New | +$133K | ﹤0.01% | 859 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1097 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1298 |
|
|
2022
Q2 | – | Sell |
-27,389
| Closed | -$450K | – | 1272 |
|
|
2022
Q1 | $450K | Buy |
+27,389
| New | +$450K | ﹤0.01% | 798 |
|
|
2021
Q4 | – | Sell |
-32,855
| Closed | -$472K | – | 1783 |
|
|
2021
Q3 | $472K | Sell |
32,855
-33,945
| -51% | -$488K | ﹤0.01% | 1038 |
|
|
2021
Q2 | $1.04M | Sell |
66,800
-29,102
| -30% | -$451K | ﹤0.01% | 610 |
|
|
2021
Q1 | $958K | Buy |
95,902
+33,022
| +53% | +$330K | ﹤0.01% | 628 |
|
|
2020
Q4 | $472K | Buy |
62,880
+26,238
| +72% | +$197K | ﹤0.01% | 869 |
|
|
2020
Q3 | $141K | Sell |
36,642
-1,373
| -4% | -$5.28K | ﹤0.01% | 1068 |
|
|
2020
Q2 | $189K | Buy |
38,015
+512
| +1% | +$2.55K | ﹤0.01% | 1019 |
|
|
2020
Q1 | $75K | Buy |
37,503
+19,552
| +109% | +$39.1K | ﹤0.01% | 1125 |
|
|
2019
Q4 | $58K | Buy |
+17,951
| New | +$58K | ﹤0.01% | 1356 |
|
|
2019
Q3 | – | Sell |
-47,732
| Closed | -$181K | – | 1339 |
|
|
2019
Q2 | $181K | Buy |
+47,732
| New | +$181K | ﹤0.01% | 988 |
|
|
2019
Q1 | – | Sell |
-27,701
| Closed | -$218K | – | 1263 |
|
|
2018
Q4 | $218K | Buy |
27,701
+17,075
| +161% | +$134K | ﹤0.01% | 1005 |
|
|
2018
Q3 | $81K | Buy |
+10,626
| New | +$81K | ﹤0.01% | 1371 |
|
|
2017
Q4 | – | Sell |
-10,480
| Closed | -$55K | – | 1595 |
|
|
2017
Q3 | $55K | Buy |
+10,480
| New | +$55K | ﹤0.01% | 1191 |
|
|
2017
Q2 | – | Sell |
-33,605
| Closed | -$280K | – | 1304 |
|
|
2017
Q1 | $280K | Buy |
33,605
+4,264
| +15% | +$35.5K | ﹤0.01% | 829 |
|
|
2016
Q4 | $186K | Sell |
29,341
-37,284
| -56% | -$236K | ﹤0.01% | 954 |
|
|
2016
Q3 | $296K | Buy |
+66,625
| New | +$296K | ﹤0.01% | 701 |
|